Nav: Home

Rockefeller University's Elaine Fuchs, Ph.D., named 2016 Vanderbilt Prize recipient

November 28, 2016

Elaine Fuchs, Ph.D., whose innovative use of reverse genetics has helped redefine the study of skin diseases and cancer stem cells, is the recipient of the 2016 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

Fuchs is the Rebecca C. Lancefield Professor and head of the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development at Rockefeller University in New York, and, since 1988, a Howard Hughes Medical Institute (HHMI) investigator.

She is the 11th recipient of the Vanderbilt Prize in Biomedical Science. Established by Vanderbilt University School of Medicine in 2006, the competitive prize honors women scientists with a "stellar record" of research accomplishments who have made significant contributions to mentoring other women in science.

Prize winners receive an honorarium, meet with Vanderbilt faculty and deliver a Flexner Discovery Lecture. They also mentor Vanderbilt Prize Scholars, women who are pursuing graduate studies in the biomedical sciences in the School of Medicine.

Fuchs will receive the prize on March, 30, 2017, when she is scheduled to give a Flexner Discovery Lecture.

"Dr. Fuchs is a world leader in stem cell research and pioneered the approach of reverse genetics to decipher human diseases. In addition to her many contributions to our understanding of genetic diseases of the skin, she is an inspiring researcher who is a passionate mentor and advocate for careers in science for women," said Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean of the Vanderbilt University School of Medicine. "I want to congratulate her as the recipient of this year's prize."

Fuchs grew up in a suburb of Chicago, majored in Chemistry at the University of Illinois, and earned her Ph.D. in Biochemistry from Princeton University. As a postdoctoral fellow in the lab of the late Howard Green, M.D., at MIT, she studied the growth and differentiation of epidermal keratinocytes.

Her work there demonstrated that keratins - the fibrous structural proteins that protect epithelial cells from mechanical stress - were likely distinct proteins coming from different genes that were differentially expressed.

In 1980, Fuchs was recruited by the University of Chicago as the first woman faculty member in Biochemistry. There she was mentored by the late Janet Rowley, M.D., and Susan Lindquist, Ph.D., winner of the 2014 Vanderbilt Prize in Biomedical Science, who died last month.

Fuchs' lab immediately set about to clone and sequence various keratin genes. It employed a reverse genetics approach, transgenic mice that expressed mutant genes, to elucidate the function of the normal keratin proteins.

One mutation resulted in a disease that resembled epidermolysis bullosa simplex (EBS), a human skin disease characterized by severe blistering. Skin biopsies from EBS patients confirmed that the disease resulted from keratin mutations.

While at the University of Chicago, Fuchs began studies that led to her current focus - how multipotent stem cells of mammalian skin give rise to the epidermis and hair follicles. After moving to Rockefeller University in 2002, her team developed a way to fluorescently tag these slow-proliferating cells.

The approach yielded insights into normal tissue formation and wound repair, and malignant transformation as well. In 2011, her lab defined how stem cells can acquire mutations that go on to initiate squamous cell carcinoma, a type of skin cancer.

Fuchs has received numerous honors for her scientific achievements, including the National Medal of Science from the National Science Foundation and the E.B. Wilson Medal from the American Society for Cell Biology. She is a member of the National Academy of Sciences and the American Academy of Arts and Sciences.

In 2010 she received the L'Oréal-UNESCO Award in the Life Sciences. The award recognizes outstanding women scientists who also have been a source of support, motivation and inspiration for other women in science.
-end-
For a complete list of Vanderbilt Prize winners, go to https://medschool.vanderbilt.edu/dean and click on "Vanderbilt Prize."

Vanderbilt University Medical Center

Related Stem Cells Articles:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.
More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.
Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.
First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.
Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.
New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.
NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.
Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.
More Stem Cells News and Stem Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.